Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Breakthrough designation is pivotal

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Apr 22, 2022 4:24pm

90 Views

Post# 34625094

RE:RE:RE:RE:RE:Breakthrough designation is pivotal

"Gorf79 the clown" forgets to take into consideration that Roger has 7.5M reasons to make this work. And that on top of that, it's the pride to make it to FDA approval that is even more rewarding in terms of pride, after all 12 years.

Nooe. "Gorf79 the clown" Is not even able to simplify his thinking! And he brags himself as being a smart guy!!!

<< Previous

Bullboard Posts

Next >>

Rick Rule’s election insights: Gold, USD, and Canadian gas